United States Radioimmunoassay Market Size, Share, Growth, Trends, Industry Analysis & Forecast 2026–2034

2. What is the expected CAGR of the U.S. Radioimmunoassay Market?

The market is expected to register a CAGR of 4.25% during the forecast period 2026–2034.

3. What are the major factors driving the United States Radioimmunoassay Market?

Major growth drivers include increasing demand for sensitive diagnostic testing, rising chronic and endocrine disease prevalence, expanding clinical laboratory infrastructure, and growing pharmaceutical and biotechnology research.

4. What are the major applications of radioimmunoassay?

RIA is used in selected thyroid function assessments, reproductive hormone testing, insulin measurement, therapeutic drug monitoring, biomarker research, and specialized clinical investigations.

5. What are the major challenges facing the U.S. Radioimmunoassay Market?

Key challenges include competition from nonradioactive immunoassays, radioactive-material handling requirements, regulatory compliance, waste disposal, staff training, and laboratory operating costs.

6. Which states are important in the United States Radioimmunoassay Market?

California, Texas, New York, and Florida are important regional markets because of their healthcare infrastructure, biotechnology industries, academic institutions, and medical research facilities.

7. Who are the key companies operating in the United States Radioimmunoassay Market?

Major companies include Danaher (Beckman Coulter), Berthold Technologies, DIAsource ImmunoAssays, BioCheck, IBL International, Merck KGaA, Abbexa, Institute of Isotopes, Marin Biologic Laboratories, and Demeditec Diagnostics.

About Renub Research

Renub Research is a market research and consulting company providing industry analysis, market forecasts, competitive intelligence, and strategic insights across global industries. Its research reports help businesses, investors, and decision-makers understand market opportunities, industry developments, competitive dynamics, and future growth prospects.